نتائج البحث

Assessment of Drug Interaction Potential Between the Hepatitis C Virus Direct‐Acting Antiviral Agents Elbasvir/Grazoprevir and the Nucleotide Analog Reverse‐Transcriptase Inhibitor Tenofovir Disoproxil Fumarate.

• Authors : Feng, Hwa‐Ping¹ (AUTHOR) ; Guo, Zifang¹ (AUTHOR); Caro, Luzelena¹ (AUTHOR)

• Source: Clinical Pharmacology in Drug Development. Oct2019, Vol. 8 Issue 7, p962-970. 9p.

تفاصيل العنوان

Drug-Drug Interaction of Omeprazole With the HCV Direct-Acting Antiviral Agents Paritaprevir/Ritonavir and Ombitasvir With and Without Dasabuvir.

• Authors : Polepally, Akshanth R.¹; Dutta, Sandeep¹; Hu, Beibei¹

• Source: Clinical Pharmacology in Drug Development. Jul/Aug2016, Vol. 5 Issue 4, p269-277. 9p.

تفاصيل العنوان

Pharmacokinetics, Tolerability, and Safety of Glecaprevir/Pibrentasvir Co-formulated Bilayer Tablet Following Repeated Administration in Healthy Chinese Adults.

• Authors : Kalluri HV; Clinical Pharmacology, AbbVie Inc, North Chicago, IL, USA.; Oberoi RK

Subjects: Antiviral Agents* ; Hepatitis C*/Hepatitis C*/Hepatitis C*/drug therapy; Adult

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2023 Oct; Vol. 12 (10), pp. 945-955. Date of Electronic Publication: 2023 Sep 04.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Pharmacokinetics and Safety Evaluation of Maribavir in Healthy Japanese and Matched White Participants: A Phase 1, Open-Label Study.

• Authors : Song I; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA.; Suttle B

Subjects: East Asian People* ; White People* ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacokinetics

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2023 Jun; Vol. 12 (6), pp. 645-654. Date of Electronic Publication: 2023 Apr 10.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Assessment of Drug Interaction Potential Between the Hepatitis C Virus Direct‐Acting Antiviral Agents Elbasvir/Grazoprevir and the Nucleotide Analog Reverse‐Transcriptase Inhibitor Tenofovir Disoproxil Fumarate

• Authors : William D. Hanley; Yali Zhu; William L. Marshall

Subjects: Adult; Male; Elbasvir

• Source: Clinical Pharmacology in Drug Development. 8:962-970

تفاصيل العنوان

A Phase 1 Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK-1654 in Healthy Adults.

• Authors : Aliprantis AO; Merck & Co., Inc., Kenilworth, New Jersey, USA.; Wolford D

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/administration & dosage ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/adverse effects ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/pharmacokinetics

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 May; Vol. 10 (5), pp. 556-566. Date of Electronic Publication: 2020 Oct 30.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Assessment of Pharmacokinetic Interaction Between Letermovir and Fluconazole in Healthy Participants.

• Authors : Adedoyin A; Merck & Co., Inc., Kenilworth, New Jersey, USA.; Fancourt C

Subjects: Acetates/Acetates/Acetates/*administration & dosage ; Antifungal Agents/Antifungal Agents/Antifungal Agents/*administration & dosage ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*administration & dosage

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 Feb; Vol. 10 (2), pp. 198-206. Date of Electronic Publication: 2020 Jul 22.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct-Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications.

• Authors : Bednasz, Cindy J.¹ ; Venuto, Charles S.^1,2; Ma, Qing¹

• Source: Clinical Pharmacology in Drug Development. Mar/Apr2017, Vol. 6 Issue 2, p135-139. 5p.

تفاصيل العنوان

Pharmacokinetic Profile of a Generic Formulation of Sofosbuvir and Its Metabolite GS-331007 in Healthy Chinese Subjects.

• Authors : Shen Z; Institute of Immunology, Academy of Translational Medicine, The First Hospital of Jilin University, Jilin University, Changchun, People's Republic of China.; Zhu X

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacokinetics ; Drugs, Generic/Drugs, Generic/Drugs, Generic/*pharmacokinetics ; Sofosbuvir/Sofosbuvir/Sofosbuvir/*pharmacokinetics

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2019 Nov; Vol. 8 (8), pp. 1073-1080. Date of Electronic Publication: 2019 Mar 22.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

An Open-Label, Single-Dose, Human Mass Balance Study of Amenamevir in Healthy Male Adults.

• Authors : Kato K; Astellas Pharma Inc., Tsukuba, Japan.; den Adel M

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacokinetics ; Oxadiazoles/Oxadiazoles/Oxadiazoles/*pharmacokinetics; Adult

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2019 Jul; Vol. 8 (5), pp. 595-602. Date of Electronic Publication: 2018 Nov 09.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان